Maternal Health, Neonatology and Perinatology (Jul 2023)

Benzylpenicillin concentrations in umbilical cord blood and plasma of premature neonates following intrapartum doses for group B streptococcal prophylaxis

  • Amadou Samb,
  • Thomas H. Dierikx,
  • Yuma A. Bijleveld,
  • Timo R. de Haan,
  • Caspar J. Hodiamont,
  • Elisabeth van Leeuwen,
  • Anton H. L. C. van Kaam,
  • Ron A. A. Mathôt,
  • Douwe H. Visser

DOI
https://doi.org/10.1186/s40748-023-00163-3
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background and method Dutch obstetrics guideline suggest an initial maternal benzylpenicillin dose of 2,000,000 IU followed by 1,000,000 IU every 4 h for group-B-streptococci (GBS) prophylaxis. The objective of this study was to evaluate whether concentrations of benzylpenicillin reached concentrations above the minimal inhibitory concentrations (MIC) in umbilical cord blood (UCB) and neonatal plasma following the Dutch guideline. Results Forty-six neonates were included. A total of 46 UCB samples and 18 neonatal plasma samples were available for analysis. Nineteen neonates had mothers that received intrapartum benzylpenicillin. Benzylpenicillin in UCB corresponded to concentrations in plasma drawn directly postpartum (R2 = 0.88, p < 0.01). A log-linear regression suggested that benzylpenicillin concentrations in neonates remained above the MIC threshold 0.125 mg/L up to 13.0 h after the last intrapartum dose. Conclusions Dutch intrapartum benzylpenicillin doses result in neonatal concentrations above the MIC of GBS.

Keywords